Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL EXOME SEQUENCING INDUSTRY
2.1 Summary about Exome Sequencing Industry
2.2 Exome Sequencing Market Trends
2.2.1 Exome Sequencing Production & Consumption Trends
2.2.2 Exome Sequencing Demand Structure Trends
2.3 Exome Sequencing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Agilent HaloPlex
4.2.2 Agilent SureSelect
4.2.3 Agilent SureSelect QXT
4.2.4 Illumina TruSeq Exome
4.2.5 Roche Nimblegen SeqCap
4.2.6 MYcroarray MYbaits
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Mendelian disease and rare syndrome gene discovery
4.3.2 The research of complex diseases
4.3.3 Mouse exome sequencing
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Agilent HaloPlex
5.2.2 Agilent SureSelect
5.2.3 Agilent SureSelect QXT
5.2.4 Illumina TruSeq Exome
5.2.5 Roche Nimblegen SeqCap
5.2.6 MYcroarray MYbaits
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Mendelian disease and rare syndrome gene discovery
5.3.2 The research of complex diseases
5.3.3 Mouse exome sequencing
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Agilent HaloPlex
6.2.2 Agilent SureSelect
6.2.3 Agilent SureSelect QXT
6.2.4 Illumina TruSeq Exome
6.2.5 Roche Nimblegen SeqCap
6.2.6 MYcroarray MYbaits
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Mendelian disease and rare syndrome gene discovery
6.3.2 The research of complex diseases
6.3.3 Mouse exome sequencing
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Agilent HaloPlex
7.2.2 Agilent SureSelect
7.2.3 Agilent SureSelect QXT
7.2.4 Illumina TruSeq Exome
7.2.5 Roche Nimblegen SeqCap
7.2.6 MYcroarray MYbaits
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Mendelian disease and rare syndrome gene discovery
7.3.2 The research of complex diseases
7.3.3 Mouse exome sequencing
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Agilent HaloPlex
8.2.2 Agilent SureSelect
8.2.3 Agilent SureSelect QXT
8.2.4 Illumina TruSeq Exome
8.2.5 Roche Nimblegen SeqCap
8.2.6 MYcroarray MYbaits
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Mendelian disease and rare syndrome gene discovery
8.3.2 The research of complex diseases
8.3.3 Mouse exome sequencing
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Agilent HaloPlex
9.2.2 Agilent SureSelect
9.2.3 Agilent SureSelect QXT
9.2.4 Illumina TruSeq Exome
9.2.5 Roche Nimblegen SeqCap
9.2.6 MYcroarray MYbaits
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Mendelian disease and rare syndrome gene discovery
9.3.2 The research of complex diseases
9.3.3 Mouse exome sequencing
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Illumina TruSeq Exome
10.1.2 Thermo Fisher
10.1.3 Roche
10.1.4 Angilent
10.1.5 Eurofins
10.1.6 Sengenics
10.1.7 Ambry
10.1.8 Macrogen
10.1.9 BGI
10.1.10 Novo Gene
10.2 Exome Sequencing Sales Date of Major Players (2017-2020e)
10.2.1 Illumina TruSeq Exome
10.2.2 Thermo Fisher
10.2.3 Roche
10.2.4 Angilent
10.2.5 Eurofins
10.2.6 Sengenics
10.2.7 Ambry
10.2.8 Macrogen
10.2.9 BGI
10.2.10 Novo Gene
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT